Baird Medical Investment Holdings (BDMDW) Shares Outstanding (Weighted Average) (2024 - 2025)
Baird Medical Investment Holdings (BDMDW) recorded quarterly Shares Outstanding (Weighted Average) of $430.0 in Q2 2025, up 152.94% quarter-over-quarter from $170.0 in Q2 2024, and up 152.94% on a YoY basis from $170.0 in Q2 2024.
Baird Medical Investment Holdings (BDMDW) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends
Baird Medical Investment Holdings' Shares Outstanding (Weighted Average) history runs 2 years deep, the most recent figure standing at $430.0 for Q2 2025.
- In Q2 2025, Shares Outstanding (Weighted Average) rose 152.94% year-over-year to $430.0; the TTM figure through Jun 2025 stood at $430.0 (up 152.94% YoY), while the FY2022 annual figure was $25.6 million, changed N/A from the prior year.
- Shares Outstanding (Weighted Average) was $430.0 for Q2 2025 at Baird Medical Investment Holdings, up from $170.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $430.0 in Q2 2025 to a low of $170.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Baird Medical Investment Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 430.00 |
| Jun 30, 2024 | 170.00 |